Vikrant Vats

719 total citations
18 papers, 545 citations indexed

About

Vikrant Vats is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Vikrant Vats has authored 18 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cardiology and Cardiovascular Medicine, 3 papers in Internal Medicine and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Vikrant Vats's work include Atrial Fibrillation Management and Outcomes (3 papers), Natural Antidiabetic Agents Studies (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Vikrant Vats is often cited by papers focused on Atrial Fibrillation Management and Outcomes (3 papers), Natural Antidiabetic Agents Studies (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). Vikrant Vats collaborates with scholars based in United States and India. Vikrant Vats's co-authors include J.K Grover, Satyajeet S. Rathi, Nihar Ranjan Biswas, Neerja Gupta, Nikhil Tandon, Naomi Aronson, Elbert S. Huang, David J Samson, Edith A. Nutescu and Meenakshi Jolly and has published in prestigious journals such as Blood, CHEST Journal and Journal of Ethnopharmacology.

In The Last Decade

Vikrant Vats

17 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vikrant Vats United States 10 219 89 70 58 56 18 545
G. Saravanan India 12 269 1.2× 84 0.9× 26 0.4× 58 1.0× 46 0.8× 23 489
Elba Leiva Chile 15 145 0.7× 102 1.1× 84 1.2× 30 0.5× 62 1.1× 24 675
Parviz Khajehdehi Iran 15 148 0.7× 33 0.4× 60 0.9× 59 1.0× 67 1.2× 31 885
Verónica Mujica Chile 15 188 0.9× 46 0.5× 106 1.5× 15 0.3× 67 1.2× 26 654
Bhawana Sharma India 15 227 1.0× 82 0.9× 21 0.3× 45 0.8× 150 2.7× 38 918
Alireza Merrikhi Iran 12 89 0.4× 79 0.9× 23 0.3× 51 0.9× 40 0.7× 38 481
Philip B. Mellen United States 10 140 0.6× 61 0.7× 229 3.3× 17 0.3× 112 2.0× 13 1.2k
Hossein Imani Iran 14 101 0.5× 25 0.3× 27 0.4× 89 1.5× 100 1.8× 67 605
Manfred J. Mueller Germany 10 189 0.9× 43 0.5× 165 2.4× 32 0.6× 212 3.8× 14 1.3k
Rafel Masià Spain 15 177 0.8× 87 1.0× 399 5.7× 60 1.0× 91 1.6× 24 1.1k

Countries citing papers authored by Vikrant Vats

Since Specialization
Citations

This map shows the geographic impact of Vikrant Vats's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikrant Vats with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikrant Vats more than expected).

Fields of papers citing papers by Vikrant Vats

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vikrant Vats. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikrant Vats. The network helps show where Vikrant Vats may publish in the future.

Co-authorship network of co-authors of Vikrant Vats

This figure shows the co-authorship network connecting the top 25 collaborators of Vikrant Vats. A scholar is included among the top collaborators of Vikrant Vats based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vikrant Vats. Vikrant Vats is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Grant, Mark D, Margaret Piper, Julia Bohlius, et al.. (2015). Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update. Europe PMC (PubMed Central). 18 indexed citations
2.
Samson, David J, et al.. (2013). Screening for methicillin-resistant Staphylococcus aureus: A comparative effectiveness review. American Journal of Infection Control. 42(2). 148–155. 20 indexed citations
3.
Grant, Mark D, Margaret Piper, Julia Bohlius, et al.. (2013). Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment. 5 indexed citations
4.
Soni, Nilam J., David J Samson, Vikrant Vats, et al.. (2013). Procalcitonin‐guided antibiotic therapy: A systematic review and meta‐analysis. Journal of Hospital Medicine. 8(9). 530–540. 58 indexed citations
5.
Ratko, Thomas A, et al.. (2013). Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non–Small-Cell Lung Cancer. 2 indexed citations
6.
Samson, David J, et al.. (2013). Screening for Methicillin-Resistant Staphylococcus Aureus (MRSA). 9 indexed citations
7.
Soni, Nilam J., et al.. (2012). Procalcitonin-Guided Antibiotic Therapy [Internet]. 1 indexed citations
8.
Aggarwal, Rohit, Caitlyn T. Wilke, A. Simon Pickard, et al.. (2009). Psychometric Properties of the EuroQol-5D and Short Form-6D in Patients with Systemic Lupus Erythematosus. The Journal of Rheumatology. 36(6). 1209–1216. 68 indexed citations
9.
Vats, Vikrant, et al.. (2007). Hospital Policies for Treatment of Acute Decompensated Heart Failure. Annals of Pharmacotherapy. 41(4). 562–567. 3 indexed citations
10.
Vats, Vikrant, et al.. (2007). Survey of hospitals for guidelines, policies, and protocols for anticoagulants. American Journal of Health-System Pharmacy. 64(11). 1203–1208. 22 indexed citations
11.
Wittkowsky, Ann K., et al.. (2006). Outcomes of Oral Anticoagulant Therapy Managed by Telephone vs In-Office Visits in an Anticoagulation Clinic Setting. CHEST Journal. 130(5). 1385–1389. 46 indexed citations
12.
Vats, Vikrant, Edith A. Nutescu, Jack Ansell, et al.. (2006). Quality of Warfarin Management in Anticoagulation Clinics in the U.S.. Blood. 108(11). 627–627. 1 indexed citations
13.
Grover, J.K, et al.. (2002). Hypoglycemic and antihyperglycemic effect of Brassica juncea diet and their effect on hepatic glycogen content and the key enzymes of carbohydrate metabolism. Molecular and Cellular Biochemistry. 241(1-2). 95–101. 28 indexed citations
14.
Grover, J.K, et al.. (2002). Effect of feeding aqueous extract of Pterocarpus marsupium on glycogen content of tissues and the key enzymes of carbohydrate metabolism. Molecular and Cellular Biochemistry. 241(1-2). 53–59. 77 indexed citations
15.
Rathi, Satyajeet S., J.K Grover, Vikrant Vats, & Nihar Ranjan Biswas. (2002). Prevention of experimental diabetic cataract by Indian Ayurvedic plant extracts. Phytotherapy Research. 16(8). 774–777. 93 indexed citations
16.
Vats, Vikrant, J.K Grover, Nikhil Tandon, Satyajeet S. Rathi, & Neerja Gupta. (2001). Treatment with extracts of Momordica charantia and Eugenia jambolana prevents hyperglycemia and hyperinsulinemia in fructose fed rats. Journal of Ethnopharmacology. 76(2). 139–143. 92 indexed citations
17.
Vats, Vikrant, et al.. (2000). Nefazodone – a new anti-depressant. Journal of Institute of Medicine Nepal. 22(1 & 2). 2 indexed citations
18.
Vats, Vikrant, et al.. (1999). Ritonavir - An effective drug against HIV. Journal of Institute of Medicine Nepal. 21(1 & 2).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026